Event Information

2-part CUA Educational Session

Type
Webinar

EVENT DETAILS

Display Date
Friday June 28, 2024
Display Date Line 2
7:30 pm PT
Location
Virtual
Speaker
Kim Chi, Daniel Heng, Krista Noonan & Ricardo Rendon

ACCREDITATION

Accreditation
Section 1 Group Learning Credits
Event Description

2-part CUA Educational Session

Session begins at 19:30

Part 1 - Insights on Early Stage RCC Detection & Emerging Management Strategies

Chair: Ricard Rendon 

Speaker: Daniel Heng

OBJECTIVES
By participating in this learning program, healthcare providers can expect to:

  • Recognize early RCC disease stage symptoms and underlying risk factors associated with recurrence rates
  • Assess recent adjuvant RCC clinical trial data and their impact on current clinical practice
  • Identify key patient factors important for the consideration of adjuvant therapy in early stage RCC

Part 2 - PRECISE: Personalized Medicine and Case-Based Education on PARP inhibitors in Prostate Cancer

Chair: Kim Chi 

Speaker: Krista Noonan

OBJECTIVES

By participating in this learning program, healthcare providers can expect to:

  • Discuss the importance of genetic testing for their patients with advanced prostate cancer.
  • Understand the efficacy and safety data from randomized control trials investigating PARPi in mCRPC
  • Apply the practical knowledge gained from real-world, case-based discussion surrounding PARPi use in patients with mCRPC